Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam.

NCT ID: NCT00370487

Last Updated: 2006-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2860 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-09-30

Study Completion Date

2004-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There have been no studies in developing countries assessing the safety of midlevel providers (MLP) compared to physicians in performing first-trimester manual vacuum aspiration abortion. In South Africa and Viet Nam, MLP (midwives and physician assistants) are trained and accredited to perform first trimester abortions to increase women's access to safe abortion services. To assess the safety of abortions performed by midlevel provider compared to physicians, complication rates of first-trimester manual vacuum aspiration are compared between types of providers in the two countries. We test the null hypothesis that the two types of providers provide abortions equally safely.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective

There have been no studies in developing countries assessing the safety of midlevel providers (MLP) compared to physicians in performing first-trimester manual vacuum aspiration abortion. In South Africa and Viet Nam, MLP (midwives and physician assistants) are trained and accredited to perform first trimester abortions to increase women's access to safe abortion services. Complication rates of first-trimester manual vacuum aspiration are compared between types of providers in the two countries.

Methods:

A randomized, two-sided controlled equivalence trial was conducted to compare rates of abortion complications. An a priori margin of equivalence of 4.5% with 80% power and a 95% CI ( = 0.025) was used. Women presenting for an induced abortion at up to 12 weeks' gestation were randomly assigned to a physician or a midlevel provider for manual vacuum aspiration and followed-up 10 to 14 days later. Complications were recorded during the abortion procedure, before discharge from the clinic and at follow-up. The study included 25 providers and 2894 cases, 1160 in South Africa and 1734 in Viet Nam.

Results:

Complication rates were 1.4 per 100 for MLP and 0 for physicians in South Africa. In Viet Nam, complication rates were 1.2 per 100 for MLP and 1.1 per 100 for physicians. In both countries, complication rates satisfied the pre-determined statistical criteria for equivalence. In South Africa, the difference in complication rates for mid-level providers and physicians was 1.4 per 100 (CI=0.4 to 2.7). In Viet Nam, the difference in complication rates for mid-level providers and physicians was 0.1 per 100 (CI= -1.0 to 1.2). There were no major immediate complications. Delayed complications were retained products and infection.

Conclusions:

First trimester manual vacuum aspiration abortions performed by trained and accredited midlevel providers in South Africa and Viet Nam were comparable in safety to those performed by physicians. Given appropriate training, midlevel health care providers can provide first trimester manual vacuum aspiration abortions as safely as physician abortion providers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abortion, Induced

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Abortion Midlevel providers South Africa Viet Nam

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* gestation of no more than 12 weeks as estimated by pelvic examination and date of LMP
* age 18 or above
* residence within the catchment area specified for each clinic
* willing to return to clinic for follow-up visit or agree to a telephone or home-based interview
* be able to understand the information given to them and to make personal decisions on whether or not to participate in the study as determined by the study staff
* consent given to participate in the study and consent form signed

Exclusion Criteria

* uterine sizing of beyond 12 weeks gestation
* under age 18
* unwilling or unable to return to clinic for follow-up visit.
* unwilling to provide consent for participation in the study
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Cape Town

OTHER

Sponsor Role collaborator

Hanoi Obstetrics and Gynecology Hospital

OTHER

Sponsor Role collaborator

World Health Organization

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Margaret Hoffman, M.D.

Role: PRINCIPAL_INVESTIGATOR

Women's Health Research Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, South Africa

ND Vy, MD

Role: PRINCIPAL_INVESTIGATOR

National Hospital of Obstetrics and Gynecology, 43 Trang Thi, Hanoi, Viet Nam

My Huong Nguyen, MD

Role: STUDY_DIRECTOR

National Hospital of Obstetrics and Gynecology, 43 Trang Thi, Hanoi, Viet Nam

Jane Harries, PhD

Role: STUDY_DIRECTOR

Women's Health Research Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A15324;A15325

Identifier Type: -

Identifier Source: org_study_id